HD17 for Intermediate Stage Hodgkin Lymphoma

NCT01356680 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1100

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone)
DRUG: ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)
RADIATION: 30Gy IF-RT (Involved-Field Radiotherapy)
RADIATION: 30Gy IN-RT (Involved-Node Radiotherapy)

Sponsor

University of Cologne